EUDA Health Holdings Net Income
| EUDA Stock | 0.89 0.05 5.95% |
As of the 17th of February 2026, EUDA Health shows the Mean Deviation of 7.46, variance of 162.91, and Standard Deviation of 12.76. EUDA Health Holdings technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
EUDA Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing EUDA Health's valuation are provided below:EUDA Health Holdings does not today have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EUDA Health. Projected growth potential of EUDA fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive EUDA Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding EUDA Health Holdings requires distinguishing between market price and book value, where the latter reflects EUDA's accounting equity. The concept of intrinsic value - what EUDA Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push EUDA Health's price substantially above or below its fundamental value.
It's important to distinguish between EUDA Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding EUDA Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, EUDA Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
EUDA Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to EUDA Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of EUDA Health.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in EUDA Health on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding EUDA Health Holdings or generate 0.0% return on investment in EUDA Health over 90 days. EUDA Health is related to or competes with American Well, Hyperfine, ZEN Graphene, Quince Therapeutics, Fonar, Precision BioSciences, and Fractyl Health. More
EUDA Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure EUDA Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess EUDA Health Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 72.37 | |||
| Value At Risk | (17.24) | |||
| Potential Upside | 9.52 |
EUDA Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for EUDA Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as EUDA Health's standard deviation. In reality, there are many statistical measures that can use EUDA Health historical prices to predict the future EUDA Health's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (1.03) | |||
| Total Risk Alpha | (1.70) | |||
| Treynor Ratio | (1.83) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of EUDA Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
EUDA Health February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (1.82) | |||
| Mean Deviation | 7.46 | |||
| Coefficient Of Variation | (1,275) | |||
| Standard Deviation | 12.76 | |||
| Variance | 162.91 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (1.03) | |||
| Total Risk Alpha | (1.70) | |||
| Treynor Ratio | (1.83) | |||
| Maximum Drawdown | 72.37 | |||
| Value At Risk | (17.24) | |||
| Potential Upside | 9.52 | |||
| Skewness | 0.0878 | |||
| Kurtosis | 7.18 |
EUDA Health Holdings Backtested Returns
EUDA Health Holdings secures Sharpe Ratio (or Efficiency) of -0.0784, which denotes the company had a -0.0784 % return per unit of risk over the last 3 months. EUDA Health Holdings exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm EUDA Health's Standard Deviation of 12.76, variance of 162.91, and Mean Deviation of 7.46 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.55, which means possible diversification benefits within a given portfolio. As returns on the market increase, EUDA Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding EUDA Health is expected to be smaller as well. At this point, EUDA Health Holdings has a negative expected return of -1.0%. Please make sure to confirm EUDA Health's coefficient of variation, total risk alpha, skewness, as well as the relationship between the information ratio and maximum drawdown , to decide if EUDA Health Holdings performance from the past will be repeated in the future.
Auto-correlation | 0.64 |
Good predictability
EUDA Health Holdings has good predictability. Overlapping area represents the amount of predictability between EUDA Health time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of EUDA Health Holdings price movement. The serial correlation of 0.64 indicates that roughly 64.0% of current EUDA Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.64 | |
| Spearman Rank Test | 0.64 | |
| Residual Average | 0.0 | |
| Price Variance | 0.25 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, EUDA Health Holdings reported net income of (17.6 Million). This is 105.16% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 103.08% higher than that of the company.
EUDA Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EUDA Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EUDA Health could also be used in its relative valuation, which is a method of valuing EUDA Health by comparing valuation metrics of similar companies.EUDA Health is currently under evaluation in net income category among its peers.
EUDA Fundamentals
| Return On Asset | -0.64 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | (0.37) % | ||||
| Current Valuation | 33.99 M | ||||
| Shares Outstanding | 37.81 M | ||||
| Shares Owned By Insiders | 49.60 % | ||||
| Shares Owned By Institutions | 0.24 % | ||||
| Number Of Shares Shorted | 98.87 K | ||||
| Price To Sales | 6.15 X | ||||
| Revenue | 4.01 M | ||||
| Gross Profit | 1.16 M | ||||
| EBITDA | (17.42 M) | ||||
| Net Income | (17.6 M) | ||||
| Total Debt | 1.27 M | ||||
| Book Value Per Share | (0.10) X | ||||
| Cash Flow From Operations | (2.03 M) | ||||
| Short Ratio | 0.13 X | ||||
| Earnings Per Share | 0.02 X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 117 | ||||
| Beta | -0.15 | ||||
| Market Capitalization | 31.76 M | ||||
| Total Asset | 1.73 M | ||||
| Retained Earnings | (50.1 M) | ||||
| Working Capital | (3.38 M) | ||||
| Net Asset | 1.73 M |
About EUDA Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EUDA Health Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EUDA Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EUDA Health Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether EUDA Health Holdings is a strong investment it is important to analyze EUDA Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact EUDA Health's future performance. For an informed investment choice regarding EUDA Stock, refer to the following important reports:Check out You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EUDA Health. Projected growth potential of EUDA fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive EUDA Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding EUDA Health Holdings requires distinguishing between market price and book value, where the latter reflects EUDA's accounting equity. The concept of intrinsic value - what EUDA Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push EUDA Health's price substantially above or below its fundamental value.
It's important to distinguish between EUDA Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding EUDA Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, EUDA Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.